483 Recipharm Pharmaservices Private Feb 2019

483 Recipharm Pharmaservices Private Feb 2019

Marcus Ray FDA$119.00 - Available Now

FDA investigators audited the Recipharm Pharmaservices Private - Bangalore, India facility and issued inspectional observations (via FDA 483) on 01 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Feb 2019
  • Location: Bangalore, India
  • FEI: 3009150119
Add To Cart